InfuSystem, Ventis Pharma enter pain management marketing deal

InfuSystem (NSYE:INFU) announced today that it entered into a national sales and marketing agreement with Ventis Pharma.

Rochester Hills, Michigan-based InfuSystem’s partnership with Ventis will focus on sales and marketing for the latter’s patented Endura-Kit brand of Enduracaine, a local anesthetic compound. The kit consists of three non-opioid drugs: tetracaine, lidocaine and epinephrine.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0